Close

Dr Laurie Tomlinson

MBBS MSc PhD

Associate Professor

Room
248a

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Tel.
0207 927 2922

Laurie trained in Medicine and continues to do clinical work as an honorary Consultant Nephrologist at Brighton and Sussex University Hospitals NHS Trust. Having trained as a specialist she worked as a clinical lecturer at the University of Cambridge before moving to LSHTM to take the MSc in epidemiology.She joined LSHTM in 2013 after gaining a Wellcome Trust Intermediate fellowship.


Affiliations

Faculty of Epidemiology and Population Health
Department of Non-communicable Disease Epidemiology

Centres

Centre for Global Chronic Conditions

Teaching

Laurie teaches on a number of courses and is a co-organiser of the Professional Certificate in Pharmacoepidemiology and Pharmascovigilance. She has previously been co-organiser of the 'Introductory Course in Epidemiology and Medical Statistics (ICEMS)', the 'Study Design' module and the 'Practical Epidemiology' Distance Learning Module.

Research

Laurie's current research focuses on renal epidemiology: in the UK using large population databases, and through research studies in low and middle income countries. A major focus is effects of prescribed medications on kidney disease and the use of drugs among patients with chronic kidney disease. 

She has an interest in the crossover between chronic kidney disease and cardiovascular disease. She has been involved in many observational studies of arterial disease including setting up and running a cohort of people with CKD, examining the role that measures of arterial health play in the development of renal disease progression and mortality. She is a Principle Investigator of the multi-centre British Heart Foundation funded EARNEST study which is investigating the impact of kidney donation on cardiovascular health.

Research Area
Clinical databases
Clinical guidelines
Health services research
Electronic health records
Medicines
Discipline
Pharmacoepidemiology
Epidemiology
Medicine
Disease and Health Conditions
Cardiovascular disease
Kidney disease
Country
United Kingdom
Malawi
Uganda
South Africa
Region
European Union
Sub-Saharan Africa (all income levels)

Selected Publications

Measurement of kidney function in Malawi, South Africa, and Uganda: a multicentre cohort study.
Fabian J; Kalyesubula R; Mkandawire J; Hansen CH; Nitsch D; Musenge E; Nakanga WP; Prynn JE; Dreyer G; Snyman T
2022
The Lancet Global health
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform.
Zheng B; Green ACA; Tazare J; Curtis HJ; Fisher L; Nab L; Schultze A; Mahalingasivam V; Parker EPK; Hulme WJ
2022
BMJ (Clinical research ed.)
Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England.
Forbes H; Morton CE; Bacon S; McDonald HI; Minassian C; Brown JP; Rentsch CT; Mathur R; Schultze A; DeVito NJ
2021
BMJ: British Medical Journal
Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care.
Bidulka P; Fu EL; Leyrat C; Kalogirou F; McAllister KSL; Kingdon EJ; Mansfield KE; Iwagami M; Smeeth L; Clase CM
2020
BMC Medicine
Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study.
Fu EL; Evans M; Clase CM; Tomlinson LA; van Diepen M; Dekker FW; Carrero JJ
2020
Journal of the American Society of Nephrology : JASN
First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care.
Sinnott S-J; Douglas IJ; Smeeth L; Williamson E; Tomlinson LA
2020
BMJ-BRITISH MEDICAL JOURNAL
Comparative effects of sulphonylureas, dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care.
Wilkinson S; Williamson E; Pokrajac A; Fogarty D; Stirnadel-Farrant H; Smeeth L; Douglas IJ; Tomlinson LA
2020
Diabetes, obesity & metabolism
Factors associated with COVID-19-related death using OpenSAFELY.
Williamson EJ; Walker AJ; Bhaskaran K; Bacon S; Bates C; Morton CE; Curtis HJ; Mehrkar A; Evans D; Inglesby P
2020
Nature
Change in renal function associated with drug treatment in heart failure: national guidance.
Clark AL; Kalra PR; Petrie MC; Mark PB; Tomlinson LA; Tomson CR
2019
Heart (British Cardiac Society)
Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study.
Crellin E; Mansfield KE; Leyrat C; Nitsch D; Douglas IJ; Root A; Williamson E; Smeeth L; Tomlinson LA
2018
BMJ (Clinical research ed)
Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study.
Schmidt M; Mansfield KE; Bhaskaran K; Nitsch D; Sørensen HT; Smeeth L; Tomlinson LA
2017
BMJ (Clinical research ed)
See more Publications